Michael J. Wagner, MD

Dr. Wagner received his MD degree from Harvard Medical School and completed residency at Mt. Sinai Hospital in New York and fellowship in medical oncology at the University of Texas MD Anderson Cancer Center.  Prior to joining Dana-Farber Cancer Institute in 2023, he was a member of the faculty at the University of Washington and Fred Hutch Cancer Center, where he was also the Director of Sarcoma Clinical Research.  His research interests include angiosarcoma and other vascular sarcomas, and immunotherapy and targeted agents for bone and soft tissue sarcomas.